T Friedmann

1.5k total citations
20 papers, 1.3k citations indexed

About

T Friedmann is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, T Friedmann has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 4 papers in Oncology. Recurrent topics in T Friedmann's work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (4 papers) and RNA Interference and Gene Delivery (3 papers). T Friedmann is often cited by papers focused on Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (4 papers) and RNA Interference and Gene Delivery (3 papers). T Friedmann collaborates with scholars based in United States and United Kingdom. T Friedmann's co-authors include Doug J. Jolly, S F Wolf, Keith D. Lunnen, Webster K. Cavenee, Tetsuro Kikuchi, Nicolas de Tribolet, Hongyi Huang, Erwin G. Van Meir, Annie‐Claire Diserens and J K Yee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and British Journal of Dermatology.

In The Last Decade

T Friedmann

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Friedmann United States 13 930 500 280 139 119 20 1.3k
Eric M. Oshiro United States 14 484 0.5× 517 1.0× 338 1.2× 66 0.5× 375 3.2× 15 1.4k
J. Michael Bishop United States 13 1.1k 1.2× 393 0.8× 294 1.1× 89 0.6× 87 0.7× 15 1.7k
Sergei A. Ezhevsky United States 11 1.4k 1.5× 302 0.6× 567 2.0× 84 0.6× 70 0.6× 15 1.9k
Lalitha R. Belur United States 17 715 0.8× 485 1.0× 108 0.4× 133 1.0× 121 1.0× 35 1.1k
Russell C. DeKelver United States 15 2.0k 2.1× 673 1.3× 179 0.6× 65 0.5× 90 0.8× 29 2.2k
Takahito Yazaki Japan 17 766 0.8× 1.0k 2.0× 529 1.9× 97 0.7× 624 5.2× 36 1.5k
Johnny E. Kopinja United States 3 996 1.1× 348 0.7× 153 0.5× 107 0.8× 63 0.5× 3 1.3k
D. Morello France 19 779 0.8× 326 0.7× 133 0.5× 84 0.6× 166 1.4× 38 1.3k
Stuart H. Johnston United States 14 1.5k 1.6× 197 0.4× 221 0.8× 89 0.6× 129 1.1× 17 1.8k
Noriyuki Miyajima Japan 16 825 0.9× 333 0.7× 703 2.5× 43 0.3× 78 0.7× 31 1.5k

Countries citing papers authored by T Friedmann

Since Specialization
Citations

This map shows the geographic impact of T Friedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Friedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Friedmann more than expected).

Fields of papers citing papers by T Friedmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Friedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Friedmann. The network helps show where T Friedmann may publish in the future.

Co-authorship network of co-authors of T Friedmann

This figure shows the co-authorship network connecting the top 25 collaborators of T Friedmann. A scholar is included among the top collaborators of T Friedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Friedmann. T Friedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burns, Jane C., Louise McNeill, Chisato Shimizu, et al.. (1996). Retroviral gene transfer inXenopus cell lines and embryos. In Vitro Cellular & Developmental Biology - Animal. 32(2). 78–84. 14 indexed citations
2.
Friedmann, T. (1996). The maturation of human gene therapy. Acta Paediatrica. 85(11). 1261–1265. 14 indexed citations
3.
Iida, Aritoshi, et al.. (1996). Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. Journal of Virology. 70(9). 6054–6059. 53 indexed citations
4.
Douar, Anne, Michael Themis, Volker Sandig, T Friedmann, & Charles Coutelle. (1996). Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection.. PubMed. 3(9). 789–96. 18 indexed citations
5.
Miyanohara, Atsushi, et al.. (1995). Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors.. PubMed. 2(2). 138–42. 22 indexed citations
6.
Friedmann, T, et al.. (1995). Differentiation of PC12 cells by infection with an HSV-1 vector expressing nerve growth factor.. PubMed. 2(5). 323–35. 5 indexed citations
7.
Meir, Erwin G. Van, Klaus Roemer, Annie‐Claire Diserens, et al.. (1995). Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells.. Proceedings of the National Academy of Sciences. 92(4). 1008–1012. 41 indexed citations
8.
Meir, Erwin G. Van, Tetsuro Kikuchi, Mitsuhiro Tada, et al.. (1994). Analysis of the p53 gene and its expression in human glioblastoma cells.. PubMed. 54(3). 649–52. 293 indexed citations
9.
Friedmann, T. (1994). Gene therapy for disorders of the CNS.. PubMed. 1 Suppl 1. S47–8. 2 indexed citations
10.
Miyanohara, Atsushi, et al.. (1992). Long-term transgene expression from genetically modified hepatocytes grafted to the rat liver.. PubMed. 4(3). 261–7. 9 indexed citations
11.
Cheng, J, J K Yee, J Yeargin, T Friedmann, & Martin Haas. (1992). Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene.. PubMed. 52(1). 222–6. 59 indexed citations
12.
Miyanohara, Atsushi, et al.. (1992). Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.. PubMed. 4(3). 238–46. 35 indexed citations
13.
Roemer, Klaus, et al.. (1991). Knock-in and knock-out. Transgenes, Development and Disease: A Keystone Symposium sponsored by Genentech and Immunex, Tamarron, CO, USA, January 12-18, 1991.. PubMed. 3(4). 331–5. 5 indexed citations
14.
Short, M. Priscilla, et al.. (1990). Autocrine Differentiation of PC12 Cells Mediated by Retroviral Vectors. Developmental Neuroscience. 12(1). 34–45. 24 indexed citations
15.
Wolff, Jon A., L. J. Fisher, Li Xu, et al.. (1989). Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.. Proceedings of the National Academy of Sciences. 86(22). 9011–9014. 179 indexed citations
16.
Jolly, Doug J., et al.. (1986). Gene Expression from a Transcriptionally Disabled Retroviral Vector. Cold Spring Harbor Symposia on Quantitative Biology. 51(0). 1021–1026. 4 indexed citations
17.
Wolf, S F, et al.. (1984). Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation.. Proceedings of the National Academy of Sciences. 81(9). 2806–2810. 265 indexed citations
18.
Jolly, Douglas J., Hiroto Okayama, Paul Berg, et al.. (1983). Isolation and Characterization of a Full-Length Expressible cDNA for Human Hypoxanthine Phosphoribosyltransferase. CaltechAUTHORS (California Institute of Technology). 200 indexed citations
19.
Friedmann, T & Walter Eckhart. (1974). Virion Proteins of Polyoma Temperature-sensitive Mutants: Late Mutants. Cold Spring Harbor Symposia on Quantitative Biology. 39(0). 243–246. 5 indexed citations
20.
Brett, E M, et al.. (1967). MAST-CELL DISEASE IN CHILDREN. Report of Eleven Cases.. British Journal of Dermatology. 79(4). 197–208. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026